These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18777590)

  • 41. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
    Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
    Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
    Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
    Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease.
    Schürmann G; Brüwer M; Klotz A; Schmid KW; Senninger N; Zimmer KP
    Int J Colorectal Dis; 1999 Feb; 14(1):41-6. PubMed ID: 10207729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells.
    Schey R; Danzer C; Mattner J
    Immunobiology; 2015 Feb; 220(2):227-35. PubMed ID: 25466587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease.
    Torres MI; Le Discorde M; Lorite P; Ríos A; Gassull MA; Gil A; Maldonado J; Dausset J; Carosella ED
    Int Immunol; 2004 Apr; 16(4):579-83. PubMed ID: 15039388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intestinal dendritic cells in the regulation of mucosal immunity.
    Bekiaris V; Persson EK; Agace WW
    Immunol Rev; 2014 Jul; 260(1):86-101. PubMed ID: 24942684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
    Sturm A; de Souza HS; Fiocchi C
    Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease.
    Durant L; Stentz R; Noble A; Brooks J; Gicheva N; Reddi D; O'Connor MJ; Hoyles L; McCartney AL; Man R; Pring ET; Dilke S; Hendy P; Segal JP; Lim DNF; Misra R; Hart AL; Arebi N; Carding SR; Knight SC
    Microbiome; 2020 Jun; 8(1):88. PubMed ID: 32513301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.
    Karlsson M; Linton L; Lampinen M; Karlén P; Glise H; Befrits R; Janczewska I; Carlson M; Winqvist O; Eberhardson M
    Scand J Gastroenterol; 2014 Jan; 49(1):66-74. PubMed ID: 24188321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
    Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
    Zhang Z; Zhao X; Lv C; Li C; Zhi F
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon GJ; Day AS; Mulder CJ; Gearry RB
    World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.